Pediatric Neuro | Neurodevelopmental Treatment (NDT/Bobath) for Cerebral Palsy: A Look at the Current Evidence

Hey colleague, let's talk about something we all know: NDT, or Bobath. For decades, it's been a cornerstone of our work with kids who have CP. The hands-on approach, the focus on normalizing tone and movement patterns—it's familiar territory. But our field is moving fast, and it's crucial we keep up. So, what does the latest evidence say about NDT? A large-scale meta-analysis published in *Pediatrics* in 2022 really shook things up. Researchers looked at 34 randomized controlled trials, which included over 1,300 children with CP. Their goal was to see if NDT was truly effective. The results were surprising. When compared to no intervention, NDT showed no significant effect on motor function. Even more telling, when put head-to-head with activity-based interventions (like constraint-induced movement therapy, bimanual therapy, or goal-directed training), the activity-based approaches were moderately more effective at improving motor function. The study also found no difference between high-dose and low-dose NDT. Based on this, the authors made a strong recommendation *against* the routine use of NDT for children with CP. The evidence suggests that our time and effort are better spent on therapies that are task-specific, functional, and actively engage the child in meaningful activities. This doesn't mean we discard everything from NDT—the detailed assessment and understanding of movement are still valuable. But it does mean we should shift our primary treatment strategy towards interventions with stronger evidence for improving participation and real-world function.